Join the Fortamet group to help and get support from people like you.
Fortamet News
Metformin Use Tied to Lower Incidence of Death, Long COVID After COVID-19
THURSDAY, Sept. 19, 2024 – After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute...
Diabetes Med Metformin Could Cut Risks for Long COVID
THURSDAY, Sept. 19, 2024 – One of the most common diabetes drugs, metformin, might deliver an added bonus: Lowering users' odds for Long COVID. Long COVID can present with symptoms including chronic...
Metformin, SGLT2 Inhibitors Exhibit Significantly Lower Dementia Risk
MONDAY, July 15, 2024 – Compared with other antidiabetic classes, metformin and sodium glucose co-transporter-2 inhibitors (SGLT2is) exhibit significantly lower dementia risk, according to a review...
Timing of Metformin Important in Metformin-Treated Type 2 Diabetes
FRIDAY, June 21, 2024 – Glucose lowering by metformin is greater when given before enteral glucose among patients with type 2 diabetes controlled by metformin monotherapy, according to a study...
Paternal Metformin Use Not Linked to Major Congenital Malformations
MONDAY, June 17, 2024 – Paternal use of metformin in monotherapy is not associated with an increased risk for major congenital malformations (MCMs), according to a study published online June 18 in...
Continuing Metformin in Pregnancy Has Little Effect on Nonlive Birth
TUESDAY, June 18, 2024 – Continuing metformin and adding insulin in early pregnancy does not significantly alter the risk for nonlive birth or live birth with congenital malformations compared with...
Using Diabetes Drug Metformin Around Pregnancy Won't Raise Birth Defect Risk
TUESDAY, June 18, 2024 – Two new studies offer reassurance that using the diabetes drug metformin before and during pregnancy is not linked to birth defects. The latest findings, which apply to men...
Metformin Use Linked to Lower Odds of Myeloproliferative Neoplasms
THURSDAY, May 23, 2024 – Metformin use, including long-term use, is associated with significantly lower odds of myeloproliferative neoplasm (MPN) diagnosis, according to a study published online May...
Metformin Added to Insulin Not Beneficial for T2D in Pregnancy
TUESDAY, Dec. 12, 2023 – For pregnant women with type 2 diabetes, the addition of metformin to insulin does not affect composite adverse neonatal outcomes, according to a study published in the Dec....
Metformin May Help Young Patients With Bipolar Disorder Avoid Weight Gain
TUESDAY, Oct. 31, 2023 – Taking the drug metformin – typically used for type 2 diabetes – can help counter weight gain in young people who are taking medication for bipolar disorder, according to a n...
Dementia Incidence Increased With Termination of Metformin
FRIDAY, Oct. 27, 2023 – Terminating metformin treatment is associated with an increased incidence of dementia, according to a study published online Oct. 25 in JAMA Network Open. Scott C. Zimmerman,...
Have Diabetes? Quitting Metformin Could Take Toll on Your Brain
THURSDAY, Oct. 26, 2023 -- Millions of people with diabetes take the drug metformin to control their blood sugar levels. Meant to be taken for the long term, new research now suggests that stopping i...
Early Metformin May Not Aid Gestational Diabetes
THURSDAY, Oct. 5, 2023 – Early metformin initiation in women with gestational diabetes does not reduce the occurrence of the combination of a fasting glucose level ≥5.1 mmol/L at gestation weeks 32 o...
FDA Medwatch Alert: Viona Issues Consumer Level Voluntary Nationwide Recall of Metformin HCl Extended- Release Tablets, USP 750 mg Due to Detection of NDMA Impurity
January 12, 2022 – Cranford, New Jersey, Viona Pharmaceuticals Inc., is voluntarily recalling twenty-three (23) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg at the consumer...
FDA Medwatch Alert: Viona Issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg Due to the Detection of NDMA Impurity
December 28, 2021 – Cranford, New Jersey, Viona Pharmaceuticals Inc., is voluntarily recalling thirty three (33) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail l...